These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 8037323

  • 21. Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.
    Kresowik J, Ryan GL, Van Voorhis BJ.
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):547-9. PubMed ID: 18239018
    [Abstract] [Full Text] [Related]

  • 22. The value of curettage in diagnosis of endometrial hyperplasia.
    Xie X, Lu WG, Ye DF, Chen HZ, Fu YF.
    Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A model for the study of cystic endometrial hyperplasia in bitches.
    Chen YM, Wright PJ, Lee CS.
    J Reprod Fertil Suppl; 2001 Jan; 57():407-14. PubMed ID: 11787183
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?
    Guleria K, Agarwal N, Mishra K, Gulati R, Mehendiratta A.
    J Obstet Gynaecol Res; 2004 Jun; 30(3):181-7. PubMed ID: 15210039
    [Abstract] [Full Text] [Related]

  • 26. Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression.
    Mora LB, Diaz JI, Cantor AB, Nicosia SV.
    Ann Clin Lab Sci; 1999 Jun; 29(4):308-15. PubMed ID: 10528831
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The risk of premalignant and malignant pathology in endometrial polyps.
    Bakour SH, Khan KS, Gupta JK.
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Steroid receptor concentrations as a prognostic factor in atypical endometrial hyperplasia.
    Lindahl B, Willén R.
    Anticancer Res; 1998 Apr; 18(5B):3793-5. PubMed ID: 9854498
    [Abstract] [Full Text] [Related]

  • 34. [Effect of gestagen therapy on clinical and biochemical parameters in patients with atypical endometrial hyperplasia].
    Makarov OV, Sergeev PV, Sviridov NK, Kareva EN, Isaeva EG, Mgdesian KK, Kirpichnikova NV.
    Vopr Onkol; 2000 Apr; 46(5):570-3. PubMed ID: 11202189
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Estrogenic receptors in hyperplasia and endometrial adenocarcinoma: immunohystochemical study with image analysis].
    Sánchez Anguiano LF, Puente Ledesma L, Lares Bayona EF, Milla Villeda RH.
    Ginecol Obstet Mex; 2007 Sep; 75(9):501-8. PubMed ID: 18293624
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.